Last updated on August 2019

Long-term Extension Trial in Subjects With Atopic Dermatitis Who Participated in Previous Tralokinumab Trials - ECZTEND


Brief description of study

The purpose of this extension trial is to evaluate the long-term safety of tralokinumab.

Clinical Study Identifier: NCT03587805

Find a site near you

Start Over

LEO Pharma Investigational Site

West Bloomfield, MI United States
2.94miles
  Connect »